Withdrawing mycophenolate mofetil in treating a young kidney transplant recipient with COVID-19: A case report.

Dong ChenBo YangYan ZhangLiang ChenLai WeiWeijie ZhangXinqiang WangXiaolin TongZhishui Chen

Published in: Medicine (2020)

In certain group of COVID-19 (e.g., mild to moderate cases, young patients without comorbidities), a reduction instead of an overall withdrawal of immunosuppressant in kidney transplant recipients is feasible.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
middle aged
prognostic factors
peritoneal dialysis